Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
about
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseNatural product-based nanomedicine: recent advances and issuesPerillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesValue of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein.Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells.Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers.Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy.Biophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol.Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease.Combining nanoscale magnetic nimodipine liposomes with magnetic resonance image for Parkinson's disease targeting therapy.Interfacing Graphene-Based Materials With Neural Cells.
P2860
Q26783306-9851DB61-1325-4965-995E-79342FAD745FQ26785633-8D40023A-AEE2-4B3A-864A-BEE7292BC040Q28072442-032001B3-6EE3-4502-80C8-DFAED849E950Q36564626-7D1DB62D-18FB-48BA-BB99-86580BE2215BQ37474296-3D113140-8767-4918-B4C8-12E84952F54BQ37502278-7B8C7F87-9093-4F69-90DC-43983D7A062EQ38401187-B5A97746-DC0A-471B-A273-0DC28D6714A9Q38889576-94E7041C-DC1D-4E79-B1DE-E88E2B5F5C7FQ38949081-2EA218CB-A81B-4716-A804-2EBF227B9C06Q42065629-92716D9F-FD74-4B97-A6C3-3E852FFD3DD1Q47582990-A9B568A6-F8ED-4EF0-AAF9-F88841E870CBQ48305573-21ADF70D-B718-4F8A-A914-26514B41233BQ48354910-49E0C780-C191-42C3-918D-451951BFB0DAQ52562684-CD81D2FC-D420-4517-8965-0918011FB3B7
P2860
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
@en
type
label
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
@en
prefLabel
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
@en
P2860
P50
P356
P1433
P1476
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
@en
P2093
Maria do Carmo Pereira
Sandra Rocha
P2860
P304
P356
10.2217/NNM.14.27
P577
2014-04-01T00:00:00Z